Loading…

Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head

Background and purpose  It has been suggested that avascular osteonecrosis (AVN) of the femoral head develops early after renal transplantation. We evaluated the relationship between risk of AVN and dose of steroids administered in different time periods. Methods  Development of AVN was determined u...

Full description

Saved in:
Bibliographic Details
Published in:Acta orthopaedica 2008-01, Vol.79 (5), p.631-636
Main Authors: Shibatani, Masahiko, Fujioka, Mikihiro, Arai, Yuji, Takahashi, Kenji, Ueshima, Keiichiro, Okamoto, Masahiko, Yoshimura, Norio, Hirota, Yoshio, Fukushima, Wakaba, Kubo, Toshikazu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c523t-592f0d2270a9fcd18e5be4fa36a2f61607b573b32f17c1745312ac0a165e5b9f3
cites cdi_FETCH-LOGICAL-c523t-592f0d2270a9fcd18e5be4fa36a2f61607b573b32f17c1745312ac0a165e5b9f3
container_end_page 636
container_issue 5
container_start_page 631
container_title Acta orthopaedica
container_volume 79
creator Shibatani, Masahiko
Fujioka, Mikihiro
Arai, Yuji
Takahashi, Kenji
Ueshima, Keiichiro
Okamoto, Masahiko
Yoshimura, Norio
Hirota, Yoshio
Fukushima, Wakaba
Kubo, Toshikazu
description Background and purpose  It has been suggested that avascular osteonecrosis (AVN) of the femoral head develops early after renal transplantation. We evaluated the relationship between risk of AVN and dose of steroids administered in different time periods. Methods  Development of AVN was determined using MRI at 3-6 weeks, 9-12 weeks, 24 weeks, and 12 months after transplantation in 150 patients (96 males). We investigated possible associations between acute rejection reactions, the dose of cyclosporine, tacrolimus use, total steroid dose by the second, fourth, sixth, or eighth weeks after transplantation, and incidence of AVN. Results  There was no statistically significant difference between incidence of AVN and presence or absence of an acute rejection reaction. We found a statistically significant association between AVN incidence and the total dose of steroids administered during the first 2 months after transplantation, and there was a doseresponse relationship. No other statistically significant associations were found. Interpretation  Our findings confirm that the total dose of steroids given within the first 2 months after renal transplantation has a great influence on the incidence of AVN.
doi_str_mv 10.1080/17453670810016641
format article
fullrecord <record><control><sourceid>informahealthcare_pubme</sourceid><recordid>TN_cdi_pubmed_primary_18839369</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1080_17453670810016641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c523t-592f0d2270a9fcd18e5be4fa36a2f61607b573b32f17c1745312ac0a165e5b9f3</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EoqXwAGyQNywH_JM4iWCDyl-lSmzadXTHuW5cJfbo2qOqr8OT4kyGIlSpK1tX3znn-pixt1J8kKIVH2VT1do0opVCSGMq-YydLrONNq16_nBvqhP2KqVbIXRbdeIlO5FtqzttulP2-yveECKPjttI2duYMlL0A8-EkGcMmd_5PPrA84jceUqZKz7HkMe0qAgDTAWGkHYThAzZx8BHSBx4yhTDDffBTXsMtqSsLj5YP6wDx5fAGNBSTP7geMjBOVLxHRGG1-yFgynhm-N5xq6_f7s6_7m5_PXj4vzL5cbWSudN3SknBqUaAZ2zg2yx3mLlQBtQzkgjmm3d6K1WTjb20JxUYAVIUxeyc_qMydV3WSURun5Hfga676Xol777R30XzbtVs9tvZxz-KY4FF-D9EYBkYXKlJ-vTA6dEU2lTLdznlStlRZrhLtI09Bnup0h_RfqpPT79Jy-9TXm0QNjfxj2VL0pPvOIPfR-wlA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head</title><source>EBSCOhost SPORTDiscus with Full Text</source><creator>Shibatani, Masahiko ; Fujioka, Mikihiro ; Arai, Yuji ; Takahashi, Kenji ; Ueshima, Keiichiro ; Okamoto, Masahiko ; Yoshimura, Norio ; Hirota, Yoshio ; Fukushima, Wakaba ; Kubo, Toshikazu</creator><creatorcontrib>Shibatani, Masahiko ; Fujioka, Mikihiro ; Arai, Yuji ; Takahashi, Kenji ; Ueshima, Keiichiro ; Okamoto, Masahiko ; Yoshimura, Norio ; Hirota, Yoshio ; Fukushima, Wakaba ; Kubo, Toshikazu</creatorcontrib><description>Background and purpose  It has been suggested that avascular osteonecrosis (AVN) of the femoral head develops early after renal transplantation. We evaluated the relationship between risk of AVN and dose of steroids administered in different time periods. Methods  Development of AVN was determined using MRI at 3-6 weeks, 9-12 weeks, 24 weeks, and 12 months after transplantation in 150 patients (96 males). We investigated possible associations between acute rejection reactions, the dose of cyclosporine, tacrolimus use, total steroid dose by the second, fourth, sixth, or eighth weeks after transplantation, and incidence of AVN. Results  There was no statistically significant difference between incidence of AVN and presence or absence of an acute rejection reaction. We found a statistically significant association between AVN incidence and the total dose of steroids administered during the first 2 months after transplantation, and there was a doseresponse relationship. No other statistically significant associations were found. Interpretation  Our findings confirm that the total dose of steroids given within the first 2 months after renal transplantation has a great influence on the incidence of AVN.</description><identifier>ISSN: 1745-3674</identifier><identifier>EISSN: 1745-3682</identifier><identifier>DOI: 10.1080/17453670810016641</identifier><identifier>PMID: 18839369</identifier><language>eng</language><publisher>Basingstoke: Informa UK Ltd</publisher><subject><![CDATA[Adolescent ; Adult ; Biological and medical sciences ; Bones, joints and connective tissue. Antiinflammatory agents ; Cyclosporine - administration & dosage ; Cyclosporine - adverse effects ; Diseases of the osteoarticular system ; Dose-Response Relationship, Drug ; Female ; Femur Head Necrosis - chemically induced ; Femur Head Necrosis - etiology ; Glucocorticoids - administration & dosage ; Glucocorticoids - adverse effects ; Graft Rejection ; Humans ; Immunosuppressive Agents - administration & dosage ; Immunosuppressive Agents - adverse effects ; Kidney Transplantation - adverse effects ; Male ; Medical sciences ; Methylprednisolone - administration & dosage ; Methylprednisolone - adverse effects ; Pharmacology. Drug treatments ; Postoperative Complications - chemically induced ; Postoperative Complications - etiology ; Prednisolone - administration & dosage ; Prednisolone - adverse effects ; Risk Factors ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system ; Tacrolimus - administration & dosage ; Tacrolimus - adverse effects ; Time Factors ; Vascular bone diseases]]></subject><ispartof>Acta orthopaedica, 2008-01, Vol.79 (5), p.631-636</ispartof><rights>2008 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2008</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c523t-592f0d2270a9fcd18e5be4fa36a2f61607b573b32f17c1745312ac0a165e5b9f3</citedby><cites>FETCH-LOGICAL-c523t-592f0d2270a9fcd18e5be4fa36a2f61607b573b32f17c1745312ac0a165e5b9f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20743649$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18839369$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shibatani, Masahiko</creatorcontrib><creatorcontrib>Fujioka, Mikihiro</creatorcontrib><creatorcontrib>Arai, Yuji</creatorcontrib><creatorcontrib>Takahashi, Kenji</creatorcontrib><creatorcontrib>Ueshima, Keiichiro</creatorcontrib><creatorcontrib>Okamoto, Masahiko</creatorcontrib><creatorcontrib>Yoshimura, Norio</creatorcontrib><creatorcontrib>Hirota, Yoshio</creatorcontrib><creatorcontrib>Fukushima, Wakaba</creatorcontrib><creatorcontrib>Kubo, Toshikazu</creatorcontrib><title>Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head</title><title>Acta orthopaedica</title><addtitle>Acta Orthop</addtitle><description>Background and purpose  It has been suggested that avascular osteonecrosis (AVN) of the femoral head develops early after renal transplantation. We evaluated the relationship between risk of AVN and dose of steroids administered in different time periods. Methods  Development of AVN was determined using MRI at 3-6 weeks, 9-12 weeks, 24 weeks, and 12 months after transplantation in 150 patients (96 males). We investigated possible associations between acute rejection reactions, the dose of cyclosporine, tacrolimus use, total steroid dose by the second, fourth, sixth, or eighth weeks after transplantation, and incidence of AVN. Results  There was no statistically significant difference between incidence of AVN and presence or absence of an acute rejection reaction. We found a statistically significant association between AVN incidence and the total dose of steroids administered during the first 2 months after transplantation, and there was a doseresponse relationship. No other statistically significant associations were found. Interpretation  Our findings confirm that the total dose of steroids given within the first 2 months after renal transplantation has a great influence on the incidence of AVN.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>Cyclosporine - administration &amp; dosage</subject><subject>Cyclosporine - adverse effects</subject><subject>Diseases of the osteoarticular system</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Femur Head Necrosis - chemically induced</subject><subject>Femur Head Necrosis - etiology</subject><subject>Glucocorticoids - administration &amp; dosage</subject><subject>Glucocorticoids - adverse effects</subject><subject>Graft Rejection</subject><subject>Humans</subject><subject>Immunosuppressive Agents - administration &amp; dosage</subject><subject>Immunosuppressive Agents - adverse effects</subject><subject>Kidney Transplantation - adverse effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methylprednisolone - administration &amp; dosage</subject><subject>Methylprednisolone - adverse effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Postoperative Complications - chemically induced</subject><subject>Postoperative Complications - etiology</subject><subject>Prednisolone - administration &amp; dosage</subject><subject>Prednisolone - adverse effects</subject><subject>Risk Factors</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><subject>Tacrolimus - administration &amp; dosage</subject><subject>Tacrolimus - adverse effects</subject><subject>Time Factors</subject><subject>Vascular bone diseases</subject><issn>1745-3674</issn><issn>1745-3682</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAUhS0EoqXwAGyQNywH_JM4iWCDyl-lSmzadXTHuW5cJfbo2qOqr8OT4kyGIlSpK1tX3znn-pixt1J8kKIVH2VT1do0opVCSGMq-YydLrONNq16_nBvqhP2KqVbIXRbdeIlO5FtqzttulP2-yveECKPjttI2duYMlL0A8-EkGcMmd_5PPrA84jceUqZKz7HkMe0qAgDTAWGkHYThAzZx8BHSBx4yhTDDffBTXsMtqSsLj5YP6wDx5fAGNBSTP7geMjBOVLxHRGG1-yFgynhm-N5xq6_f7s6_7m5_PXj4vzL5cbWSudN3SknBqUaAZ2zg2yx3mLlQBtQzkgjmm3d6K1WTjb20JxUYAVIUxeyc_qMydV3WSURun5Hfga676Xol777R30XzbtVs9tvZxz-KY4FF-D9EYBkYXKlJ-vTA6dEU2lTLdznlStlRZrhLtI09Bnup0h_RfqpPT79Jy-9TXm0QNjfxj2VL0pPvOIPfR-wlA</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Shibatani, Masahiko</creator><creator>Fujioka, Mikihiro</creator><creator>Arai, Yuji</creator><creator>Takahashi, Kenji</creator><creator>Ueshima, Keiichiro</creator><creator>Okamoto, Masahiko</creator><creator>Yoshimura, Norio</creator><creator>Hirota, Yoshio</creator><creator>Fukushima, Wakaba</creator><creator>Kubo, Toshikazu</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20080101</creationdate><title>Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head</title><author>Shibatani, Masahiko ; Fujioka, Mikihiro ; Arai, Yuji ; Takahashi, Kenji ; Ueshima, Keiichiro ; Okamoto, Masahiko ; Yoshimura, Norio ; Hirota, Yoshio ; Fukushima, Wakaba ; Kubo, Toshikazu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c523t-592f0d2270a9fcd18e5be4fa36a2f61607b573b32f17c1745312ac0a165e5b9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>Cyclosporine - administration &amp; dosage</topic><topic>Cyclosporine - adverse effects</topic><topic>Diseases of the osteoarticular system</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Femur Head Necrosis - chemically induced</topic><topic>Femur Head Necrosis - etiology</topic><topic>Glucocorticoids - administration &amp; dosage</topic><topic>Glucocorticoids - adverse effects</topic><topic>Graft Rejection</topic><topic>Humans</topic><topic>Immunosuppressive Agents - administration &amp; dosage</topic><topic>Immunosuppressive Agents - adverse effects</topic><topic>Kidney Transplantation - adverse effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methylprednisolone - administration &amp; dosage</topic><topic>Methylprednisolone - adverse effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Postoperative Complications - chemically induced</topic><topic>Postoperative Complications - etiology</topic><topic>Prednisolone - administration &amp; dosage</topic><topic>Prednisolone - adverse effects</topic><topic>Risk Factors</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><topic>Tacrolimus - administration &amp; dosage</topic><topic>Tacrolimus - adverse effects</topic><topic>Time Factors</topic><topic>Vascular bone diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shibatani, Masahiko</creatorcontrib><creatorcontrib>Fujioka, Mikihiro</creatorcontrib><creatorcontrib>Arai, Yuji</creatorcontrib><creatorcontrib>Takahashi, Kenji</creatorcontrib><creatorcontrib>Ueshima, Keiichiro</creatorcontrib><creatorcontrib>Okamoto, Masahiko</creatorcontrib><creatorcontrib>Yoshimura, Norio</creatorcontrib><creatorcontrib>Hirota, Yoshio</creatorcontrib><creatorcontrib>Fukushima, Wakaba</creatorcontrib><creatorcontrib>Kubo, Toshikazu</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Acta orthopaedica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shibatani, Masahiko</au><au>Fujioka, Mikihiro</au><au>Arai, Yuji</au><au>Takahashi, Kenji</au><au>Ueshima, Keiichiro</au><au>Okamoto, Masahiko</au><au>Yoshimura, Norio</au><au>Hirota, Yoshio</au><au>Fukushima, Wakaba</au><au>Kubo, Toshikazu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head</atitle><jtitle>Acta orthopaedica</jtitle><addtitle>Acta Orthop</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>79</volume><issue>5</issue><spage>631</spage><epage>636</epage><pages>631-636</pages><issn>1745-3674</issn><eissn>1745-3682</eissn><abstract>Background and purpose  It has been suggested that avascular osteonecrosis (AVN) of the femoral head develops early after renal transplantation. We evaluated the relationship between risk of AVN and dose of steroids administered in different time periods. Methods  Development of AVN was determined using MRI at 3-6 weeks, 9-12 weeks, 24 weeks, and 12 months after transplantation in 150 patients (96 males). We investigated possible associations between acute rejection reactions, the dose of cyclosporine, tacrolimus use, total steroid dose by the second, fourth, sixth, or eighth weeks after transplantation, and incidence of AVN. Results  There was no statistically significant difference between incidence of AVN and presence or absence of an acute rejection reaction. We found a statistically significant association between AVN incidence and the total dose of steroids administered during the first 2 months after transplantation, and there was a doseresponse relationship. No other statistically significant associations were found. Interpretation  Our findings confirm that the total dose of steroids given within the first 2 months after renal transplantation has a great influence on the incidence of AVN.</abstract><cop>Basingstoke</cop><pub>Informa UK Ltd</pub><pmid>18839369</pmid><doi>10.1080/17453670810016641</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1745-3674
ispartof Acta orthopaedica, 2008-01, Vol.79 (5), p.631-636
issn 1745-3674
1745-3682
language eng
recordid cdi_pubmed_primary_18839369
source EBSCOhost SPORTDiscus with Full Text
subjects Adolescent
Adult
Biological and medical sciences
Bones, joints and connective tissue. Antiinflammatory agents
Cyclosporine - administration & dosage
Cyclosporine - adverse effects
Diseases of the osteoarticular system
Dose-Response Relationship, Drug
Female
Femur Head Necrosis - chemically induced
Femur Head Necrosis - etiology
Glucocorticoids - administration & dosage
Glucocorticoids - adverse effects
Graft Rejection
Humans
Immunosuppressive Agents - administration & dosage
Immunosuppressive Agents - adverse effects
Kidney Transplantation - adverse effects
Male
Medical sciences
Methylprednisolone - administration & dosage
Methylprednisolone - adverse effects
Pharmacology. Drug treatments
Postoperative Complications - chemically induced
Postoperative Complications - etiology
Prednisolone - administration & dosage
Prednisolone - adverse effects
Risk Factors
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
Tacrolimus - administration & dosage
Tacrolimus - adverse effects
Time Factors
Vascular bone diseases
title Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T22%3A35%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-informahealthcare_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Degree%20of%20corticosteroid%20treatment%20within%20the%20first%202%20months%20of%20renal%20transplantation%20has%20a%20strong%20influence%20on%20the%20incidence%20of%20osteonecrosis%20of%20the%20femoral%20head&rft.jtitle=Acta%20orthopaedica&rft.au=Shibatani,%20Masahiko&rft.date=2008-01-01&rft.volume=79&rft.issue=5&rft.spage=631&rft.epage=636&rft.pages=631-636&rft.issn=1745-3674&rft.eissn=1745-3682&rft_id=info:doi/10.1080/17453670810016641&rft_dat=%3Cinformahealthcare_pubme%3E10_1080_17453670810016641%3C/informahealthcare_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c523t-592f0d2270a9fcd18e5be4fa36a2f61607b573b32f17c1745312ac0a165e5b9f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/18839369&rfr_iscdi=true